Vitae

Home > Vitae

Andy Yeh Alpha

Virtual net portfolio value:$9,709,192

Net overall return per annum:27.51%

Dan Rochefort

Virtual net portfolio value:$5,276,486

Net overall return per annum:19.46%

Monica McNeil

Virtual net portfolio value:$5,221,570

Net overall return per annum:19.33%

Laura Hermes

Virtual net portfolio value:$5,201,866

Net overall return per annum:19.28%

Jonah Whanau

Virtual net portfolio value:$5,146,380

Net overall return per annum:19.14%

Chanel Holden

Virtual net portfolio value:$5,141,901

Net overall return per annum:19.13%

Peter Prince

Virtual net portfolio value:$5,133,774

Net overall return per annum:19.11%

Becky Berkman

Virtual net portfolio value:$5,135,613

Net overall return per annum:19.11%

Charlene Vos

Virtual net portfolio value:$5,126,136

Net overall return per annum:19.09%

Jacob Miramar

Virtual net portfolio value:$5,072,466

Net overall return per annum:18.96%

Fiona Sydney

Virtual net portfolio value:$5,055,978

Net overall return per annum:18.92%

Rose Prince

Virtual net portfolio value:$5,006,804

Net overall return per annum:18.79%

Olivia London

Virtual net portfolio value:$4,996,949

Net overall return per annum:18.77%

Daisy Harvey

Virtual net portfolio value:$4,989,685

Net overall return per annum:18.75%

John Fourier

Virtual net portfolio value:$4,986,469

Net overall return per annum:18.74%

Apple Boston

Virtual net portfolio value:$4,950,185

Net overall return per annum:18.65%

James Campbell

Virtual net portfolio value:$4,940,839

Net overall return per annum:18.62%

Joseph Corr

Virtual net portfolio value:$4,849,083

Net overall return per annum:18.39%

Blog+More

U.S. senators urge the Trump administration to prevent the IMF from bailing out several countries that face predatory Chinese loans.

Chanel Holden

2018-02-01 07:38:00 Thursday ET

U.S. senators urge the Trump administration to prevent the IMF from bailing out several countries that face predatory Chinese loans.

U.S. senators urge the Trump administration with a bipartisan proposal to prevent the International Monetary Fund (IMF) from bailing out several countries t

+See More

Fed's new chairman Jerome Powell testifies before Congress for the first time.

Rose Prince

2018-02-27 09:35:00 Tuesday ET

Fed's new chairman Jerome Powell testifies before Congress for the first time.

Fed's new chairman Jerome Powell testifies before Congress for the first time. He vows to prevent price instability for U.S. consumers, firms, and finan

+See More

Today, tech titans continue to reshape and even disrupt global pharmaceutical investments for both better healthspan and longer lifespan.

John Fourier

2026-10-31 12:38:00 Saturday ET

Today, tech titans continue to reshape and even disrupt global pharmaceutical investments for both better healthspan and longer lifespan.

Today tech titans and billionaires continue to reshape global pharmaceutical investments for both better healthspan and longer lifespan. We discuss, desc

+See More

Personal finance author William Danko shares 3 top secrets for better wealth creation.

Rose Prince

2018-12-01 11:37:00 Saturday ET

Personal finance author William Danko shares 3 top secrets for better wealth creation.

As the solo author of the books Millionaire Next Door and Richer Than Millionaire, William Danko shares 3 top secrets for *better wealth creation*. True pro

+See More

Yale macro economist Stephen Roach draws 3 major conclusions with respect to the Chinese long-run view of the current tech trade conflict with America.

Joseph Corr

2019-09-05 09:26:00 Thursday ET

Yale macro economist Stephen Roach draws 3 major conclusions with respect to the Chinese long-run view of the current tech trade conflict with America.

Yale macro economist Stephen Roach draws 3 major conclusions with respect to the Chinese long-run view of the current tech trade conflict with America. Firs

+See More

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle

John Fourier

2024-05-05 10:31:00 Sunday ET

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its

+See More